Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases

Institutions Share
Centers for Disease Control and Prevention (CDC), United States of America (USA) 0.61
Gilead Sciences, Inc., United States of America (USA) 0.28
University of Alberta (U of A), Canada 0.11

Return